N

Nanjing Medlander Medical Technology Co Ltd
SSE:688273

Watchlist Manager
Nanjing Medlander Medical Technology Co Ltd
SSE:688273
Watchlist
Price: 44.29 CNY 1.86% Market Closed
Market Cap: ¥4.4B

Wall Street
Price Targets

Price Targets Summary
Nanjing Medlander Medical Technology Co Ltd

There are no price targets for Nanjing Medlander Medical Technology Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Nanjing Medlander Medical Technology Co Ltd Competitors:
Price Targets
NKTX
Nkarta Inc
367% Upside
CAMT
Camtek Ltd
14% Upside

Revenue
Forecast

6% / Year
Past Growth
18% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
6% / Year
Past Growth
18% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

For the last 4 years the compound annual growth rate for Nanjing Medlander Medical Technology Co Ltd's revenue is 6%. The projected CAGR for the next 3 years is 18%.

Operating Income
Forecast

-5% / Year
Past Growth
58% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
-5% / Year
Past Growth
58% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

For the last 4 years the compound annual growth rate for Nanjing Medlander Medical Technology Co Ltd's operating income is -5%. The projected CAGR for the next 2 years is 58%.

Net Income
Forecast

-4% / Year
Past Growth
26% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
-4% / Year
Past Growth
26% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

For the last 4 years the compound annual growth rate for Nanjing Medlander Medical Technology Co Ltd's net income is -4%. The projected CAGR for the next 3 years is 26%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Nanjing Medlander Medical Technology Co Ltd's stock price target?
Not Available

Nanjing Medlander Medical Technology Co Ltd doesn't have any price targets made by Wall Street professionals.

What is Nanjing Medlander Medical Technology Co Ltd's Revenue forecast?
Projected CAGR
18%

For the last 4 years the compound annual growth rate for Nanjing Medlander Medical Technology Co Ltd's revenue is 6%. The projected CAGR for the next 3 years is 18%.

What is Nanjing Medlander Medical Technology Co Ltd's Operating Income forecast?
Projected CAGR
58%

For the last 4 years the compound annual growth rate for Nanjing Medlander Medical Technology Co Ltd's operating income is -5%. The projected CAGR for the next 2 years is 58%.

What is Nanjing Medlander Medical Technology Co Ltd's Net Income forecast?
Projected CAGR
26%

For the last 4 years the compound annual growth rate for Nanjing Medlander Medical Technology Co Ltd's net income is -4%. The projected CAGR for the next 3 years is 26%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett